We are live on ! Find out more
AI

Ariel Investments Portfolio holdings

AUM $8.93B
1-Year Est. Return 29.58%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+29.58%
3 Year Est. Return
+55.43%
5 Year Est. Return
+58.61%
10 Year Est. Return
+236.09%
AUM
$9.79B
AUM Growth
+$555M
Cap. Flow
-$424M
Cap. Flow %
-4.33%
Top 10 Hldgs %
27.73%
Holding
119
New
4
Increased
25
Reduced
79
Closed
9

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$88.7M
2
BIDU icon
Baidu
BIDU
+$63.4M
3
CVSA
Covista Inc
CVSA
+$50.8M
4
TFC icon
Truist Financial
TFC
+$38.7M
5
JLL icon
Jones Lang LaSalle
JLL
+$38.2M

Sector Composition

Rank Sector Weight
1 Financials 20.95%
2 Consumer Discretionary 19.45%
3 Industrials 15.24%
4 Communication Services 13.06%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMX icon
51
CarMax
KMX
$8.26B
$54.9M 0.56%
709,722
-281
-0% -$22.2K
CBRE icon
52
CBRE Group
CBRE
$42.9B
$51.7M 0.53%
415,508
-69,487
-14% -$7.58M
GCMG icon
53
GCM Grosvenor
GCMG
$820M
$51.4M 0.52%
4,540,686
-5,410
-0.1% -$58.2K
NTAP icon
54
NetApp
NTAP
$37.2B
$50.4M 0.51%
407,907
-72,958
-15% -$9.1M
ALL icon
55
Allstate
ALL
$67.5B
$49.4M 0.5%
260,665
+20,623
+9% +$3.66M
KEYS icon
56
Keysight
KEYS
$58.3B
$47.3M 0.48%
297,922
-56
-0% -$7.97K
COF icon
57
Capital One
COF
$134B
$46.9M 0.48%
313,102
-123,233
-28% -$17.5M
KFY icon
58
Korn Ferry
KFY
$4.28B
$46.5M 0.47%
617,727
-122,778
-17% -$8.62M
DNB
59
DELISTED
Dun & Bradstreet
DNB
$45.4M 0.46%
3,946,422
-246,027
-6% -$2.73M
SCHW
60
Charles Schwab
SCHW
$187B
$43.4M 0.44%
669,991
+86,056
+15% +$5.65M
MTN icon
61
Vail Resorts
MTN
$5.3B
$42.6M 0.43%
244,318
-2,777
-1% -$497K
MGPI icon
62
MGP Ingredients
MGPI
$375M
$42.4M 0.43%
509,442
-6,354
-1% -$525K
AFL icon
63
Aflac
AFL
$62.6B
$40.4M 0.41%
361,402
-155,572
-30% -$15.8M
DVA icon
64
DaVita
DVA
$11.7B
$40.1M 0.41%
244,828
-114,776
-32% -$17M
BIDU icon
65
Baidu
BIDU
$37.2B
$39.5M 0.4%
375,111
-718,141
-66% -$63.4M
NOV icon
66
NOV
NOV
$7B
$39.2M 0.4%
2,454,416
+336,573
+16% +$5.98M
CVS icon
67
CVS Health
CVS
$122B
$38.8M 0.4%
616,807
-52,277
-8% -$3.05M
BWA icon
68
BorgWarner
BWA
$13.9B
$38.6M 0.39%
1,064,195
+138,024
+15% +$4.55M
KKR icon
69
KKR & Co
KKR
$92.3B
$36.3M 0.37%
277,788
-43,560
-14% -$5.15M
ZBH icon
70
Zimmer Biomet
ZBH
$18.4B
$32.1M 0.33%
297,254
-147
-0% -$16K
WAL icon
71
Western Alliance Bancorporation
WAL
$8.87B
$31.4M 0.32%
+363,305
New +$28M
WEX icon
72
WEX
WEX
$6.31B
$31.3M 0.32%
+149,440
New +$27.9M
TAP icon
73
Molson Coors Class B
TAP
$8.09B
$30.3M 0.31%
526,727
+63,210
+14% +$3.38M
DHI icon
74
D.R. Horton
DHI
$42.3B
$26.8M 0.27%
140,628
-24,998
-15% -$4.39M
CNH
75
CNH Industrial
CNH
$17.5B
$26.1M 0.27%
2,350,751
-582,665
-20% -$5.93M

Similar funds

Ariel Investments's Q3 2024 Portfolio in Review

As of Q3 2024, Ariel Investments held 119 positions worth $9.79B, up 6% from $9.24B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ariel Investments withdrew a net $424M in Q3 2024, closing 9 positions and reducing 79 holdings. Its most notable exit was Stericycle Inc, an estimated $88.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Ariel Investments opened a new position in Western Alliance Bancorporation worth $31.4M.

  • Ariel Investments's largest Q3 2024 buy was Western Alliance Bancorporation: 363,305 shares worth $31.4M.
  • Ariel Investments added most to Bio-Rad Laboratories Class A in Q3 2024, an estimated $87.2M increase.
  • Ariel Investments's biggest Q3 2024 reduction was Baidu, cutting an estimated $63.4M.
  • Ariel Investments fully exited Stericycle Inc in Q3 2024, selling an estimated $88.7M.
  • Ariel Investments's ten largest holdings make up 28% of its $9.79B portfolio in Q3 2024.
  • Ariel Investments opened 4 new positions and closed 9 in Q3 2024.
  • Ariel Investments's portfolio value rose 6% quarter-over-quarter to $9.79B.

Based on Ariel Investments's 13F filing for Q3 2024, filed 13 Nov 2024.